SB 840 Missouri 2026 session
SB 840 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB 1448 (2026), SB 1327 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON
SB 840 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB 1448 (2026), SB 1327 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
In committee — last recorded action January 8, 2026
Second Read and Referred S Insurance and Banking Committee
Passage likelihood
13% Lower than most bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 20% of introduced state bills are enacted.
- Current stage Referred to committee.
- Days without action No recorded action in 200 days.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Second Read and Referred S Insurance and Banking Committee
- S First Read
- Prefiled